TFF Pharmaceuticals Inc. (TFFP) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. CVI

Go back to TFF Pharmaceuticals Inc. (TFFP) Tops Q2 EPS by 1c

TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results

August 13, 2020 4:00 PM EDT

Enters into worldwide license agreement with UNION Therapeutics for its Thin Film Freezing technology in combination with niclosamide

Closes on $25.9 million private financing to further advance its technology platform for inhalable drug products, vaccines, biologics and botanicals

Completes Phase 1 trial dosing for Voriconazole Inhalation Powder and begins Phase 1 trial for Tacrolimus Inhalation Powder

Conference call and live webcast scheduled for Thursday, August 13, 2020 at 4:30pm EDT

AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical... More